Chie Suzuki

スズキチエ | Chie Suzuki

Affiliation and department：

Research field (2)： Radiology , Pharmaceuticals - analytical and physicochemistry

Research theme for competitive and other funds (13)：

2022 - 2025 EGFRを標的とした放射線治療効果予測システムの開発と、放射線治療併用薬の最適化
2022 - 2025 Development of receptor specific imaging methods for oxytocin systems
2021 - 2024 補体活性化の画像化によるニューロン貪食のインビボ評価
2020 - 2023 がん悪液質における中枢機能障害の画像科学による病態機能解明
2019 - 2022 Development of Molecular Targeted Imaging for Prediction of Radiotherapy Effectiveness: Based on DNA Repair Mechanisms

Show all

Papers (20)：

Asuka Mizutani, Masato Kobayashi, Kodai Nishi, Ken-ichi Fujita, Kotaro Takahashi, Yuka Muranaka, Kakeru Sato, Masanori Kitamura, Chie Suzuki, Ryuichi Nishii, et al. Development of radioiodine-labeled mequitazine for evaluation of hepatic CYP2D activity. Frontiers in Pharmacology. 2024. 15
Takafumi Sugi, Tomoo Inubushi, Tomohisa Ohno, Yuya Onishi, Takashi Isobe, Takashi Shigematsu, Satoshi Hanai, Yoshiro Okada, Ryosuke Takahashi, Yuichi Tawara, et al. Neural substrates of cough control during coughing. Scientific Reports. 2024. 14. 1
Keita Sasaki, Shota Fukakusa, Yusuke Torikai, Chie Suzuki, Ikumi Sonohata, Takuto Kawahata, Yasuhiro Magata, Keiichi Kawai, Shunji Haruta. Effective nose-to-brain drug delivery using a combination system targeting the olfactory region in monkeys. Journal of controlled release : official journal of the Controlled Release Society. 2023. 359. 384-399
Kohei Nakajima, Akiyo Sugikawa, Hironobu Yasui, Kei Higashikawa, Chie Suzuki, Takahiro Natsume, Motofumi Suzuki, Hideo Takakura, Mayu Tomita, Sachi Takahashi, et al. In vivo imaging of acute physiological responses after treatment of cancer with near-infrared photoimmunotherapy. Molecular Imaging and Biology. 2023
Chie Suzuki, Toshihiro Sakai, Yasuhiro Magata. Reduced P-glycoprotein recognition of a radioiodine-labeled phosphonium cation by stilbenylation for mitochondrial membrane potential based-imaging. Bioorganic & medicinal chemistry. 2023. 84. 117260-117260

ｍore...

MISC (6)：

鈴木基史, 片山竜樹, 鈴木千恵, 中島孝平, 間賀田泰寛, 小川美香子. PETイメージング剤を用いた動脈硬化プラークにおけるニコチン受容体の発現に関する検討. 日本動脈硬化学会総会プログラム・抄録集. 2021. 53回. 195-195
鈴木基史, 片山竜樹, 鈴木千恵, 中島孝平, 間賀田泰寛, 小川美香子. PETイメージング剤を用いた動脈硬化病変におけるニコチン受容体の機能解明. JSMI Report. 2021. 14. 2. 125-125
Chie Suzuki, Atsushi B. Tsuji, Koichi Kato, Hitomi Sudo, Ming-Rong Zhang, Yasushi Arano, Tsuneo Saga. Synthesis and biological evaluation of 2-amino-2-[C-11]methyl-butanoic acid as a potential PET probe for tumor imaging. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. 2015. 58. S305-S305
鈴木千恵, 荒野泰. RIを用いたがんの診断・治療薬開発の最前線腎臓への集積を低減する^186,188Re標識薬剤の開発. 放射線と産業. 2014. 136. 27-32
鈴木千恵, 荒野泰. 腫瘍集積向上のための標識抗体の体内動態制御 (特集 RI内用療法の進歩(後編)). PET journal. 2014. 26. 36-38

ｍore...

Patents (4)：

Lectures and oral presentations (26)：

中枢性オキシトシン受容体標的 PETプローブの開発研究
(第63回日本核医学会学術総会 2023)
Development of oxytocin receptor imaging probe
(2023)
Radiosynthesis and preliminary evaluation of a novel PET probe for neuronal complement C3 activation imaging
(25th International Symposium on Radiopharmaceutical Sciences 2023)
Development of a novel Epidermal growth factor receptor tyrosine kinase (EGFR-TK) PET probe for personalized medicine
(11st China-Japan-Korea Joint Seminar on Radiopharmaceutical Chemistry 2021)
覚醒ラットにおける脳糖代謝率および脳血流量の評価
(第60回日本核医学会学術総会 2020)

ｍore...

Education (2)：

Professional career (1)：

Work history (4)：

2024/04 - 現在 Hamamatsu University School of Medicine
2016/01 - 2024/03 Hamamatsu University School of Medicine
2015/04 - 2015/12 Hamamatsu University School of Medicine
2012/04 - 2015/03 National Institutes for Quantum and Radiological Science and Technology

Awards (2)：

Association Membership(s) (3)：

THE PHARMACEUTICAL SOCIETY OF JAPAN , JAPANESE SOCIETY OF NUCLEAR MEDICINE , 日本分子イメージング学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page